Register   |   Log In Contact Us
Or login with one of the following

Log in

 

SUO 2013 SUO 2013

14th Annual Meeting of the Society of Urologic Oncology (SUO)suo

December 4 - 6, 2013

Bethesda, MD USA

SUO 2013 - Session Highlights: NEUACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+ urothelial cancer (UC): Updated analysis of product parameters, HER2 expression and safety

BETHESDA, MD USA (UroToday.com) - Dr. Leonard Gomella, professor and chairman of department urology at Thomas Jefferson University, presented an updated analysis on a multicenter, phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2 (negative prognostic factor) UC.

Read more...

SUO 2013 - Session Highlights: Marketing robotic surgery

BETHESDA, MD USA (UroToday.com) - Vincent Laudone, MD gave an insightful review of marketing strategies employed by Intuitive Surgical, Inc., hospitals, and physicians which may have led to the early inappropriate adoption of robotic surgery in the absence of comparative data.

Read more...